Table 1.
Baseline Characteristics of Patients
Simple Crossover (n = 1685) | SB Opening (n = 509) | p Value | |
---|---|---|---|
Age, yrs | 63.38 ± 11.09 | 63.67 ± 10.58 | 0.595 |
Men | 1,282 (76.1) | 400 (78.6) | 0.267 |
Hypertension | 961 (57.0) | 289 (56.8) | 0.960 |
Diabetes mellitus | 562 (33.4) | 167 (32.8) | 0.861 |
Dyslipidemia | 628 (37.3) | 207 (40.7) | 0.183 |
Current smoker | 527 (31.3) | 152 (29.9) | 0.582 |
Previous PCI | 187 (11.1) | 70 (13.8) | 0.120 |
Previous stroke | 122 (7.2) | 28 (5.5) | 0.207 |
Previous heart failure | 11 (0.7) | 4 (0.8) | 0.760 |
Ejection fraction, % | 58.43 ± 10.17 | 59.41 ± 8.77 | 0.048 |
Clinical presentation | 0.091 | ||
Stable angina | 636 (37.7) | 214 (42.0) | |
Acute coronary syndrome | 1,049 (62.3) | 295 (58.0) | |
Discharge medications | |||
Aspirin | 1,660 (98.5) | 500 (98.6) | 0.998 |
P2Y12 inhibitor | 1,664 (98.8) | 502 (99.0) | 0.804 |
Beta-blocker | 1,035 (61.4) | 285 (56.0) | 0.032 |
Calcium-channel blocker | 130 (7.7) | 44 (8.7) | 0.544 |
ACE inhibitor or ARB | 1,050 (62.3) | 297 (58.3) | 0.119 |
Statin | 1,514 (89.9) | 449 (88.2) | 0.330 |
Values are mean ± SD or n (%).
ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; PCI = percutaneous coronary intervention.